Santa Ana, Calif., FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), announces it has exclusively licensed the intellectual property relating to artificial intelligence (AI) for image-based evaluation of human embryos to improve in-vitro fertilization (IVF) success rates
Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.
Manchester, UK - Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy (ISPD).
Global Access Diagnostics (GADx) formed to expand affordable access to advanced rapid diagnostic technologies
Bedford, UK - Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, formally introduces its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.
Beverly, Mass – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following…
Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs in the treatment of solid tumours where there is a high unmet need.
Helcules, Calif. - Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of its CHT™ prepacked Foresight Pro Columns, designed to support downstream process-scale chromatography applications across different stages of biological drug development and production.
Innovate UK awards grant to Orbit Discovery to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery
The project will use microfluidic technology to improve efficiency of peptide therapeutics discovery for challenging drug targets.
Expansion of European business development team supports next phase of growth for Metrion’s ion channel drug discovery services
Optibrium™, a developer of software for drug discovery, announces the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and…
Hercules, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announces the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive…
Dotmatics strengthens leadership team as it continues to invest in organization capabilities and accelerate growth
Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, announces the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the company’s executive team as the company extends the reach of its research and data solutions globally.
seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System
Beverly, Mass. And San Diego, Calif., - seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces a partnership with Element Biosciences Inc., developer of the Element AVITI™ System.
Hercules, Calif. – Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of the CFX Duet Real-Time PCR System to support researchers in developing singleplex and duplex quantitative PCR (qPCR) assays.
Cambridge, UK : CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Dr Paul Brooks as Chief Business Officer.
FUJIFILM Irvine Scientific completes construction of Bioprocessing Innovation and Collaboration Center in China
New center opens in Suzhou New District, China, to bring local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development.
Boston, MA, Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announces it has been selected by Umicore Corporate Research and Development, which is part of global materials technology and recycling company Umicore, as informatics partner for its Corporate R&D (CRD) digitalization project.
London and Wetherby, UK: Avacta Group plc, a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading…
London and Wetherby, UK, Avacta Group plc, a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, announces that the Company has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announces that it has appointed three new hires to its commercial team. Evelyn Stevenson and Ravi Girdhar join as Director of Product Management and Director of Sales (EMEA), respectively, alongside Denise Emsden as Vice-President of People and Organizational Development.
seqWell’s plexWell technology selected by California Conservation Genomics Project for conservation genomics research
Beverly, Mass. and Los Angeles, Calif, seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing platform, announces a partnership with California Conservation Genomics Project (CCGP).
Evonetix Ltd, the synthetic biology company bringing semiconductor technology to DNA synthesis, announces it has been granted a European patent covering its unique Binary Assembly method for gene synthesis.
Dotmatics biology solution for antibody discovery streamlines data collection and workflows to accelerate antibody research and therapies
Boston, MA - Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announces the release of its Biology Solution for Antibody Discovery, a unique end-to-end software and data management package.
Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management
Boston, MA, — Dotmatics is announced as the formal name and brand for the combined entities of Insightful Science and Dotmatics. As the Insightful Science brand is retired, the new Dotmatics company is now inclusive of the Dotmatics’ enterprise scientific platform and many of scientists’ favorite applications including SnapGene, Geneious, and GraphPad Prism to offer end-to-end solutions for…
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), introduces its PhysioMimix™ ‘in-a-box’ reagent kit for Non-alcoholic steatohepatitis (NASH), the most severe form of non-alcoholic fatty liver disease (NAFLD).